Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 2901863, 9 pages
https://doi.org/10.1155/2018/2901863
Research Article

Chronic Unpredictable Mild Stress Aggravates Mood Disorder, Cognitive Impairment, and Brain Insulin Resistance in Diabetic Rat

1Pharmacology Research Center, First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China
2The Domestic First Class Construction Discipline of Chinese Medicine in Hunan University of Chinese Medicine, Changsha, Hunan, China
3Key Laboratory of Chinese Material Medical Power and Innovation Drugs Established by Provincial and Ministry, Hunan University of Chinese Medicine, Changsha, Hunan, China
4Institute of Innovation and Applied Research, Hunan University of Chinese Medicine, Changsha, Hunan, China

Correspondence should be addressed to Yuhong Wang; moc.361@701_hyw

Received 13 August 2018; Revised 29 September 2018; Accepted 21 November 2018; Published 3 December 2018

Academic Editor: Vincenzo De Feo

Copyright © 2018 Hui Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Guariguata, D. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014. View at Publisher · View at Google Scholar
  2. A. Mushtaque, R. Gulati, M. M. Hossain, and S. A. Azmi, “Prevalence of depression in patients of type 2 diabetes mellitus: A cross sectional study in a tertiary care centre,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 10, no. 4, pp. 238–241, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Wang, R. Song, Z. Chen, J. Wang, and F. Ling, “Prevalence of depressive symptoms and factors associated with it in type 2 diabetic patients: a cross-sectional study in China,” BMC Public Health, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  4. R. Bhattacharya, C. Shen, A. B. Wachholtz, N. Dwibedi, and U. Sambamoorthi, “Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression,” BMC Psychiatry, vol. 16, no. 1, 2016. View at Google Scholar · View at Scopus
  5. N. Sartorius and L. Cimino, “The co-occurrence of diabetes and depression: an example of the worldwide epidemic of comorbidity of mental and physical illness,” Annals, Academy of Medicine, Singapore, vol. 41, no. 10, pp. 430-431, 2012. View at Google Scholar · View at Scopus
  6. T. D. Habtewold, M. A. Islam, Y. T. Radie, and B. S. Tegegne, “Comorbidity of depression and diabetes: An application of biopsychosocial model,” International Journal of Mental Health Systems, vol. 10, no. 1, 2016. View at Google Scholar · View at Scopus
  7. J.-H. Lee, S. K. Park, J.-H. Ryoo et al., “The association between insulin resistance and depression in the Korean general population,” Journal of Affective Disorders, vol. 208, pp. 553–559, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. T. D. Habtewold, S. M. Alemu, and Y. G. Haile, “Sociodemographic, clinical, and psychosocial factors associated with depression among type 2 diabetic outpatients in Black Lion General Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study,” BMC Psychiatry, vol. 16, no. 1, article no. 103, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Ö. Can, Y. Öztürk, and Ü. Özkay, “Effects of Insulin and St. John's Wort Treatments on Anxiety, Locomotory Activity, Depression, and Active Learning Parameters of Streptozotocin-Diabetic Rats,” Planta Medica, vol. 77, no. 18, pp. 1970–1976, 2011. View at Publisher · View at Google Scholar
  10. A.-L. Dinel, C. André, A. Aubert, G. Ferreira, S. Layé, and N. Castanon, “Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome,” PLoS ONE, vol. 6, no. 9, Article ID e24325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Willner, “Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation,” Psychopharmacology, vol. 134, no. 4, pp. 319–329, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. de la Monte, “Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease,” Drugs, vol. 77, no. 1, pp. 47–65, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. A. A. Akintola and D. van Heemst, “Insulin, aging, and the brain: Mechanisms and implications,” Frontiers in Endocrinology, vol. 6, 2015. View at Google Scholar · View at Scopus
  14. M. Machida, S. Fujimaki, R. Hidaka, M. Asashima, and T. Kuwabara, “The insulin regulatory network in adult hippocampus and pancreatic endocrine system,” Stem Cells International, vol. 2012, Article ID 959737, 8 pages, 2012. View at Publisher · View at Google Scholar
  15. W. A. Banks, J. B. Owen, and M. A. Erickson, “Insulin in the brain: there and back again,” Pharmacology & Therapeutics, vol. 136, no. 1, pp. 82–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-B. Li, W.-H. Zhang, H.-D. Liu et al., “Protective effects of Huanglian Wendan Decoction aganist cognitive deficits and neuronal damages in rats with diabetic encephalopathy by inhibiting the release of inflammatory cytokines and repairing insulin signaling pathway in hippocampus,” Chinese Journal of Natural Medicines, vol. 14, no. 11, pp. 813–822, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. Z.-G. Li, W. Zhang, and A. A. F. Sima, “The role of impaired insulin/IGF action in primary diabetic encephalopathy,” Brain Research, vol. 1037, no. 1-2, pp. 12–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. E. C. McNay and A. K. Recknagel, “Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes,” Neurobiology of Learning and Memory, vol. 96, no. 3, pp. 432–442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. U. Imam and M. Ismail, “Effects of brown rice and white rice on expression of xenobiotic metabolism genes in type 2 diabetic rats,” International Journal of Molecular Sciences, vol. 13, no. 7, pp. 8597–8608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening,” Pharmacological Research The official journal of The Italian Pharmacological Society, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Willner, D. Sanger, and M. Oglesby, “The behavioural pharmacology of anxiety and depression,” Behavioural Pharmacology, vol. 8, no. 6-7, pp. 475-476, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Ho, M. S. Sommers, and I. Lucki, “Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression,” Neuroscience & Biobehavioral Reviews, vol. 37, no. 8, pp. 1346–1362, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A.-N. Sharma, K.-M. Elased, T.-L. Garrett et al., “Neurobehavioral deficits in db/dbdiabetic mice,” Physiology & Behavior, vol. 101, no. 5, pp. 381–388, 2010. View at Publisher · View at Google Scholar
  24. L. I. Berge and T. Riise, “Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms,” International Journal of Endocrinology, vol. 2015, Article ID 164760, 7 pages, 2015. View at Google Scholar · View at Scopus
  25. M. Shimabukuro, “Leptin resistance and lipolysis of white adipose tissue: An implication to ectopic fat disposition and its consequences,” Journal of Atherosclerosis and Thrombosis, vol. 24, no. 11, pp. 1088-1089, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Su, W. Tao, H. Wang, Y. Chen, H. Huang, and G. Chen, “Umbelliferone attenuates unpredictable chronic mild stress induced-insulin resistance in rats,” IUBMB Life, vol. 68, no. 5, pp. 403–409, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Liu, X. Zhu, Q. Lu et al., “Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 194–200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. I. Malone, S. Hanna, S. Saporta et al., “Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory,” Pediatric Diabetes, vol. 9, no. 6, pp. 531–539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Kamal, G.-J. Biessels, I. J. A. Urban, and W. H. Gispen, “Hippocampal synaptic plasticity in streptozotocin-diabetic rats: Impairment of long-term potentiation and facilitation of long-term depression,” Neuroscience, vol. 90, no. 3, pp. 737–745, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Kalalian-Moghaddam, T. Baluchnejadmojarad, M. Roghani, F. Goshadrou, and A. Ronaghi, “Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats,” European Journal of Pharmacology, vol. 698, no. 1–3, pp. 259–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Moheet, S. Mangia, and E. R. Seaquist, “Impact of diabetes on cognitive function and brain structure,” Annals of the New York Academy of Sciences, vol. 1353, no. 1, pp. 60–71, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Fink, N. Buchmann, C. Tegeler, E. Steinhagen-Thiessen, I. Demuth, and G. Doblhammer, “Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany,” PLoS ONE, vol. 12, no. 10, 2017. View at Google Scholar · View at Scopus
  33. S. Sasaki-Hamada, H. Sacai, and J.-I. Oka, “Diabetes onset influences hippocampal synaptic plasticity in streptozotocin-treated rats,” Neuroscience, vol. 227, pp. 293–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Pittenger and R. S. Duman, “Stress, depression, and neuroplasticity: a convergence of mechanisms,” Neuropsychopharmacology Official Publication of the American College of Neuropsychopharmacology, vol. 33, no. 1, pp. 88–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Sharma and R. Taliyan, “Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes,” Pharmacological Research, vol. 113, pp. 320–326, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. A.-O. Shpakov, “Function activity of the brain insulin signaling system in norm and in type 2 diabetes mellitus,” Rossiiskii Fiziologicheskii Zhurnal Imeni I. M. Sechenova, vol. 101, pp. 1103–1127, 2015. View at Google Scholar
  37. E. C. McNay, C. T. Ong, R. J. McCrimmon, J. Cresswell, J. S. Bogan, and R. S. Sherwin, “Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance,” Neurobiology of Learning and Memory, vol. 93, no. 4, pp. 546–553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. B. S. Diniz, S. Fisher-Hoch, and J. McCormick, “The association between insulin resistance, metabolic variables, and depressive symptoms in Mexican-American elderly: A population-based study,” International Journal of Geriatric Psychiatry, vol. 33, no. 2, pp. e294–e299, 2018. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Mehta, T. R. Singh, and M. Udayabanu, “Quercetin ameliorates chronic unpredicted stress-induced behavioral dysfunction in male Swiss albino mice by modulating hippocampal insulin signaling pathway,” Physiology & Behavior, vol. 182, pp. 10–16, 2017. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Kubota, N. Kubota, and T. Kadowaki, “Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway,” Cell Metabolism, vol. 25, no. 4, pp. 797–810, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. O. Vadas, J. E. Burke, X. Zhang, A. Berndt, and R. L. Williams, “Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases,” Science Signaling, vol. 4, no. 195, p. re2, 2011. View at Publisher · View at Google Scholar
  42. S. Hazra, S. Kumar, G. K. Saha, and A. C. Mondal, “Reversion of BDNF, Akt and CREB in hippocampus of chronic unpredictable stress induced rats: Effects of phytochemical, Bacopa Monnieri,” Psychiatry Investigation, vol. 14, no. 1, pp. 74–80, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Kothari, Y. Luo, T. Tornabene et al., “High fat diet insuces brain insulin resistance and cognitive impairment in mice,” Biochimica et Biophysica Acta, vol. 1863, no. 2, pp. 499–508, 2017. View at Publisher · View at Google Scholar